Through case-based scenarios, this activity will explore how key molecular findings and patient/tumor characteristics influence treatment decisions, striving towards optimized outcomes for patients with GE cancers.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://preview.healio.com/cme/oncologyce/gastrointestinal-cancers/20241231/gastric-cancer-enhanced-clinical-decision-making-via-molecular-profiling/overview
- Start Date: 2024-12-31 06:00:00
- End Date: 2024-12-31 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Astellas - Amount: 25000.0 - Is Kind Support: False Source: Bristol Myers Squibb - Amount: 25000.0 - Is Kind Support: False Source: Merck & Co., Inc. - Amount: 25000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest